Clinical trial

Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

NCT02145611

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE4

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2016-08-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Hypertensionunresolved

Endothelial Dysfunctionunresolved

Interventions

GlibenclamideDRUG · verified · RxNorm: glyburide

VildagliptinDRUG

Sponsors & collaborators

Dr. José Fernando Vilela-Martin MD PhDlead sponsor

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02145611 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.